News - OS Fund

OS Fund — Building A Global Biological Immune System

Future Literacy

OS Fund — Building A Global Biological Immune System

Future Literacy

Increasing the probability that the human race will thrive. tl:dr After selling my company Braintree (Venmo) to eBay in 2013, I started a venture fund, OS Fund, personally investing $100M. My...

See More

Q1 2021 Portfolio Company Updates: $9B increase in NIH funding, Group COVID Testing, Major Partnership Announcements, Fundraising News

Newsletters

Q1 2021 Portfolio Company Updates: $9B increase in NIH funding, Group COVID Testing, Major Partnership Announcements, Fundraising News

Newsletters

While the vaccine roll-out has helped us start our social normalization process, one thing that has remained is the increased attention paid to scientific innovation and acceleration of progress in...

See More

Q4 2020 Portfolio Company Updates: The Biotech Revolution, COVID-19 Vaccines and At-Home Testing, Partnerships and Funding News

Newsletters

Q4 2020 Portfolio Company Updates: The Biotech Revolution, COVID-19 Vaccines and At-Home Testing, Partnerships and Funding News

Newsletters

The seismic shifts of 2020 have sparked an acceleration of innovations which have armed humanity with awareness and ability to create powerful, longstanding positive impact via next generation...

See More

Q3 2020 Portfolio Company Updates: Adaptability and Future Literacy, COVID-19 Testing, Partnership and Funding News

Newsletters

Q3 2020 Portfolio Company Updates: Adaptability and Future Literacy, COVID-19 Testing, Partnership and Funding News

Newsletters

There is no doubt that the complex impact of the coronavirus pandemic has challenged us all to reflect on previous strategies, both personally and professionally, and adapt to the rapidly evolving...

See More

Q2 2020 Portfolio Company Updates: The Fight Against COVID-19, Sustainability Successes, AI for Drug Discovery Victories

Newsletters

Q2 2020 Portfolio Company Updates: The Fight Against COVID-19, Sustainability Successes, AI for Drug Discovery Victories

Newsletters

The second quarter was an unprecedented time in our history; and while much of the world remains in various states of shutdown, our areas of focus at OS Fund have taken center stage. Companies, not...

See More

A Lesson From SARS-CoV-2: We Need to Build A Real-Time Global Biological Immune System

Future Literacy

A Lesson From SARS-CoV-2: We Need to Build A Real-Time Global Biological Immune System

Future Literacy

A coronavirus has ravaged our planet. Humanity brought to its knees by 29,829 nucleotides of “bad news wrapped in a protein.” In 2014, Jeff Klunzinger and I designed OS Fund to build...

See More

Scaling AI-Driven Drug Discovery: twoXAR Signs Four Partnerships in a Year and Celebrates Five-year Anniversary

Future Literacy

Scaling AI-Driven Drug Discovery: twoXAR Signs Four Partnerships in a Year and Celebrates Five-year Anniversary

Future Literacy

Last year we announced our investment in twoXAR, a company building a next generation drug discovery platform. As twoXAR’s five-year anniversary comes to pass, they have managed to vastly exceed...

See More